CLINICAL_TRIALS
trial_result
· 2026-01-09
Clinical Trial Update: A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight [Phase 3]
Summary
A Phase 3 trial in China evaluating CagriSema for weight loss in individuals with obesity completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Obesity or Overweight | Phase 3 | Status: COMPLETED